Massive transfusion coagulopathy.

Department of Anesthesiology, Emory University School of Medicine, Cardiothoracic Anesthesiology and Critical Care, Emory Healthcare, Atlanta, GA 30322, USA.
Seminars in Hematology (Impact Factor: 3.36). 02/2006; 43(1 Suppl 1):S59-63. DOI: 10.1053/j.seminhematol.2005.11.019
Source: PubMed

ABSTRACT Coagulopathy following massive transfusion is a consequence of post-traumatic and surgical hemorrhage. Bleeding following massive transfusion can occur due to hypothermia, dilutional coagulopathy, platelet dysfunction, fibrinolysis, or hypofibrinogenemia. Transfusion of 15 to 20 units of blood products causes dilutional thrombocytopenia, and both antiplatelet agents (eg, clopidogrel [Plavix, Sanofi, Bridgewater, NJ]) and hemostatic inhibitors (eg, low-molecular-weight heparins, pentasaccharides, and direct thrombin inhibitors) are contributing factors to bleeding. Tests for platelet dysfunction are not readily available. Excessive fibrinolysis and low fibrinogen are also causes of bleeding in these patients. Currently, however, there are several agents that have been reported to be effective for the prophylaxis of hemorrhage in surgical patients, including aprotinin for cardiac surgery, orthopedic surgery, and hepatic transplantation, and the off-label use of recombinant activated factor VII (NovoSeven, Novo Nordisk, Bagsvaerd, Denmark) as rescue therapy for life-threatening hemorrhage.

  • [Show abstract] [Hide abstract]
    ABSTRACT: A novel polyamino polycarboxylic pyridine derivative ligand, N,N,N1,N1-(2,6-bis((3-(aminoethyl)-5-methyl-1H-pyrazol-1-yl)methyl)pyridine)hexakis(acetic acid) (L), was designed and synthesized with the motive that it is able to sensitize the emission of lanthanides. Its corresponding Eu(III) and Tb(III) complexes Na4EuLCl3·3H2O and Na4TbLCl3·5H2O were successfully prepared. The ligand and the complexes were characterized by elemental analysis, IR, MS, NMR and TG–DTA. The luminescence properties of the compounds in solid state were investigated; each complex had very narrow emission bands and strong luminescence intensity up to about 10,000. The TG–DTA studies showed that the initial decomposition temperature of both complexes was over 250°C, elucidating the complexes had a high thermal stability. Meanwhile, the comparison with similar complexes suggested that the ligand with more coordination sites possessed more efficient antenna effect. To explore the potential medicinal value of L, the binding interaction of L and bovine serum albumin (BSA) was carried out by fluorescence spectrum. The studies indicated that the reaction between L and BSA was a static quenching procedure. The binding site number n and binding constant Ka were calculated according to the double logarithm regression equation. The thermodynamic parameters showed the Van der Waals and hydrogen bond interactions were the mainly impulse to the reaction.
    Journal of Organometallic Chemistry - J ORGANOMET CHEM. 01/2011; 696(10):2040-2046.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Massive haemorrhage requires massive transfusion (MT) to maintain adequate circulation and haemostasis. For optimal management of massively bleeding patients, regardless of aetiology (trauma, obstetrical, surgical), effective preparation and communication between transfusion and other laboratory services and clinical teams are essential. A well-defined MT protocol is a valuable tool to delineate how blood products are ordered, prepared, and delivered; determine laboratory algorithms to use as transfusion guidelines; and outline duties and facilitate communication between involved personnel. In MT patients, it is crucial to practice damage control resuscitation and to administer blood products early in the resuscitation. Trauma patients are often admitted with early trauma-induced coagulopathy (ETIC), which is associated with mortality; the aetiology of ETIC is likely multifactorial. Current data support that trauma patients treated with higher ratios of plasma and platelet to red blood cell transfusions have improved outcomes, but further clinical investigation is needed. Additionally, tranexamic acid has been shown to decrease the mortality in trauma patients requiring MT. Greater use of cryoprecipitate or fibrinogen concentrate might be beneficial in MT patients from obstetrical causes. The risks and benefits for other therapies (prothrombin complex concentrate, recombinant activated factor VII, or whole blood) are not clearly defined in MT patients. Throughout the resuscitation, the patient should be closely monitored and both metabolic and coagulation abnormalities corrected. Further studies are needed to clarify the optimal ratios of blood products, treatment based on underlying clinical disorder, use of alternative therapies, and integration of laboratory testing results in the management of massively bleeding patients.
    BJA British Journal of Anaesthesia 12/2013; 111 Suppl 1:i71-i82. · 4.24 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Eine Koagulopathie hat sich als unabhängiger Prädiktor für die perioperative Mortalität erwiesen. Deshalb wird die Erhaltung einer stabilen Gerinnungssituation als eine wichtige Voraussetzung angesehen, um die perioperative Morbidität und Mortalität zu reduzieren. Eine intakte Gerinnung ist an enge Rahmenbedingungen bezüglich Körpertemperatur, Säure-Basen-Haushalt, Plasma-Kalzium-Spiegel und Hämatokrit geknüpft. Notfallsituationen, wie schwer traumatisierte Patienten und ausgeprägte operationsbedingte Blutungen, können einen erheblichen Einfluss auf die Rahmenbedingungen einer intakten Hämostase ausüben und eine klinisch relevante Blutung fördern. Dabei sind die herkömmlichen Globaltests der Gerinnung bei der Diagnostik von Störungen der Rahmenbedingungen wenig hilfreich, da diese Untersuchungen ausschließlich mit Plasma bei einer genormten Temperatur von 37°C mit einem Kalziumüberschuss und bei ausgeglichenem Säure-Basen-Status durchgeführt werden. Damit sind die Laborergebnisse im Kontext der instabilen Rahmenbedingungen der Gerinnung wenig aussagekräftig. Deshalb ist die Kenntnis der Auswirkungen von veränderten, die Gerinnung beeinflussenden Rahmenbedingungen eine Voraussetzung zur Vermeidung schwerer Koagulopathien mit möglicherweise letalem Ausgang. Es konnte gezeigt werden, dass ein deutliches Risiko für das Auftreten klinisch bedeutsamer Koagulopathien besteht, wenn eine Körpertemperatur ≤34°C, ein pH-Wert ≤7,15, eine Konzentration des ionisierten Kalziums unter 0,9 mmol/l und/oder ein Hämatokrit unter 30–35% vorliegen. Das kombinierte Auftreten der angeführten Faktoren verschlechtert die Blutgerinnungsfähigkeit zusätzlich. Besonders nachteilig wirkt sich das gleichzeitige Auftreten von Hypothermie und Acidose aus. Die Optimierung der Rahmenbedingungen sollte möglichst früh, also bereits an der Unfallstelle beginnen und im Schockraum und OP-Saal fortgeführt werden. Der folgende Artikel soll anhand der Literaturdaten eine Übersicht zu den die Gerinnung beeinflussenden Rahmenbedingungen geben und Möglichkeiten zum Erhalt einer intakten Hämostase aufzeigen.
    Der Anaesthesist 03/2007; 56(3). · 0.85 Impact Factor